These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7398717)

  • 1. Neutral proteinase inhibitors and antimetastatic effects in mice.
    Giraldi T; Sava G; Kopitar M; Brzin J; Turk V
    Eur J Cancer (1965); 1980 Apr; 16(4):449-54. PubMed ID: 7398717
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimetastatic effects and tumor proteinase inhibition by spleen intracellular inhibitors of neutral proteinases.
    Giraldi T; Sava G; Kopitar M; Brzin J; Suhar A; Turk V
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1301-6. PubMed ID: 7200031
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimetastatic effects of a leukocyte intracellular inhibitor of neutral proteases.
    Giraldi T; Kopitar M; Sava G
    Cancer Res; 1977 Oct; 37(10):3834-5. PubMed ID: 908024
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental models to identify antimetastatic drugs: are we there yet? A position paper.
    Zucker S
    Ann N Y Acad Sci; 1999 Jun; 878():208-11. PubMed ID: 10415732
    [No Abstract]   [Full Text] [Related]  

  • 5. Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.
    Salsbury AJ; Burrage K; Hellmann K
    Cancer Res; 1974 Apr; 34(4):843-9. PubMed ID: 4814997
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma.
    James SE; Salsbury AJ
    Cancer Res; 1974 Apr; 34(4):839-42. PubMed ID: 4814996
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimetastatic activity of a synthetic serine protease inhibitor, FOY-305 (Foypan).
    Ohkoshi M; Sasaki Y
    In Vivo; 2005; 19(1):133-6. PubMed ID: 15796165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal enzyme inhibitors and antimetastatic activity in the mouse.
    Giraldi T; Nisi C; Sava G
    Eur J Cancer (1965); 1977 Nov; 13(11):1321-3. PubMed ID: 303995
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice.
    Leto G; Tumminello FM; Gebbia N; Woynarowska B; Bernacki RJ
    Anticancer Res; 1990; 10(1):265-9. PubMed ID: 2334138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimetastatic effect of 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole.
    Heyes J
    J Natl Cancer Inst; 1974 Jul; 53(1):279-80. PubMed ID: 4835110
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental vitamin K deficiency and spontaneous metastases.
    Hilgard P
    Br J Cancer; 1977 Jun; 35(6):891-2. PubMed ID: 871374
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of lung tumour colony reduction caused by coumarin anticoagulation.
    Hilgard P; Maat B
    Eur J Cancer (1965); 1979 Feb; 15(2):183-7. PubMed ID: 436894
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel plasmin-inhibitor inhibits the growth of human tumor xenografts and decreases metastasis number.
    Szende B; Okada Y; Tsuda Y; Horvath A; Bökönyi G; Okamoto S; Wanaka K; Kéri G
    In Vivo; 2002; 16(5):281-6. PubMed ID: 12494864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antimetastatic effect of macrophages restored by indomethacin: concomitant tumor immunity model.
    Jukić MK; Luetić AT; Skudar-Lukinović V; Andreis I
    Coll Antropol; 2010 Sep; 34(3):899-904. PubMed ID: 20977080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary tumor growth and formation of spontaneous lung metastases in mice bearing Lewis carcinoma treated with proteinase inhibitors.
    Giraldi T; Sava G; Perissin L; Zorzet S
    Anticancer Res; 1984; 4(4-5):221-4. PubMed ID: 6435503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the total proteolytic activity and inhibitory potential of tumor and lung tissue in mice during growth and metastatic spread of malignant neoplasms].
    Veksler IG; Veremeenko KN; Riabukha VN; Pogorelaia NF; Khaniuchenko SI
    Eksp Onkol; 1987; 9(5):68-70. PubMed ID: 3319519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide].
    Umanskiĭ VIu; Stefanov AV; Los' GV; Andronova TM; Balitskiĭ KP
    Dokl Akad Nauk SSSR; 1986; 286(2):474-6. PubMed ID: 3004870
    [No Abstract]   [Full Text] [Related]  

  • 18. [Elastase activity during growth and metastasis of tumors andthe pharmacological effects in C57Bl/6 mice].
    Chubinskaia SG
    Eksp Onkol; 1990; 12(1):53-6. PubMed ID: 2298144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimetastatic effect of CpG DNA mediated by type I IFN.
    Hafner M; Zawatzky R; Hirtreiter C; Buurman WA; Echtenacher B; Hehlgans T; Männel DN
    Cancer Res; 2001 Jul; 61(14):5523-8. PubMed ID: 11454702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis.
    Lee DY; Park K; Kim SK; Park RW; Kwon IC; Kim SY; Byun Y
    Clin Cancer Res; 2008 May; 14(9):2841-9. PubMed ID: 18451252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.